Unlock more results with a Fundz subscription — Get started today!
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Giiant Pharma Inc Announced The Closing Of Us$11M In Seed Financing To Develop Its Precision Delivery Technology Platform In Gastroenterology
Giiant Pharma Inc Announced The Closing Of Us$11M In Seed Financing To Develop Its Precision Delivery Technology Platform In Gastroenterology
Company Info
Company news
Wed, 06 Sep 2023 07:00:00 GMT
Palisade Bio Transforms GI-Focused Pipeline Through Exclusive Worldwide Licensing Agreement with Giiant Pharma, Inc. for Multiple Oral Drug Candidates Targeting Inflammatory Bowel Disease - GlobeNewswire
Fri, 21 May 2021 07:00:00 GMT
Giiant Pharma Inc Announced the Closing of US$11m in Seed Financing to Develop Its Precision Delivery Technology Platform in Gastroenterology - Business Wire
Thu, 20 Feb 2025 08:00:00 GMT
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from - GlobeNewswire
Tue, 19 Mar 2024 07:00:00 GMT
AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion - The Globe and Mail

Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.